Biblio
Donor genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight. Front Immunol. 2024;15:1350470.
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry. Best Pract Res Clin Haematol. 2024;37(1):101541.
. HLA allele and haplotype frequencies of registered stem cell donors in Chile. Front Immunol. 2023;14:1175135.
. CCR5Δ32 mutations do not determine COVID-19 disease course. Int J Infect Dis. 2021.
. Immunogenetics in stem cell donor registry work: The DKMS example (Part 2). Int J Immunogenet. 2020.
Non-invasive determination of CMV serostatus from dried buccal swab samples: assay development, validation and application to 1.2 million samples. J Infect Dis. 2020.
. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. 2020.
Toward an optimal global stem cell donor recruitment strategy. PLoS One. 2014;9(1):e86605.
. Regional HLA Differences in Poland and Their Effect on Stem Cell Donor Registry Planning. PLoS One. 2013;8(9):e73835.
.